Skip to content
Aperlena

Belgium - Vaccines for veterinary medicine - Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease

Awarded Contract award

Key facts

Awarded
Awarded value
€2,385,950
Estimated value
€3,200,000
Where
Belgium
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33651690 Vaccines for veterinary medicine
Original language
English
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 5 hours ago
Notice number
675871-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Awarded
  2. Published

Description

REASON FOR PURCHASING The Commission has to maintain an estimated stock of at least 528.000 doses of live attenuated Lumpy Skin Disease (LSD) vaccine in storage in order to make it rapidly available in case it is needed. In addition, this stock of 528.000 doses of live attenuated vaccine should be replaced quickly, within 4 weeks, when depleted, in order to maintain the Union’s capability to respond to an emergency. PROCUREMENT DESCRIPTION The purpose of the contract is: • The purchase of an estimated maximum 2.640.000 doses of live attenuated homologous vaccine against LSD. This will be executed with one initial purchase of 528.000 and up to four (4) replenishments, of 528.000 doses each, upon request from the Commission. • The storage of an initial stock of 528.000 doses, readily available for delivery to any of the destinations listed in the technical specifications, that can be replaced, if depleted, partially or totally, up to 4 times until the end of the contract, upon request from the Commission. • The timely delivery of maximum 2.640.000 doses divided in as many consignments as needed to any of the destinations listed in the technical specifications • The storage of any vaccines in stock at the end of the contract for the remainder of their shelf life • The proper destruction and disposal of any unused vaccine at the end of its self life.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 5 hours ago

More from this buyer

Full buyer profile

1 open tender right now

Recent awards

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,306,115
10,020 open across Europe right now 72% below sector average
Buyer track record on Aperlena
19 notices tracked · 4 awarded
€22,219,025 in awarded contracts

Never miss a tender like this

38 new notices in Medical equipment & pharmaceuticals in Belgium in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language